Corrigendum To: Comparison of Induction Therapy in Non-High Risk Acute Promyelocytic Leukemia With Arsenic Trioxide or in Combination With Atra Leukemia Research 66 (2018) 85–88(S0145212618300250)(10.1016/J.Leukres.2018.01.019)

Corrigendum To: Comparison of Induction Therapy in Non-High Risk Acute Promyelocytic Leukemia With Arsenic Trioxide or in Combination With Atra Leukemia Research 66 (2018) 85–88(S0145212618300250)(10.1016/J.Leukres.2018.01.019) Publisher Pubmed

Ghavamzadeh A¹ ; Jalili M¹ ; Rostami S¹ ; Yaghmaie M¹ ; Aliabadi LS¹ ; Mousavi SA¹ ; Vaezi M¹ ; Fumani HK¹ ; Jahani M¹ ; Alimoghaddam K¹

Show Affiliations

1. Hematology-Oncology and Stem Cell Transplantation Research Center/Tehran University of Medical Sciences, Tehran, Iran

Source: Leukemia Research Published:2018

Abstract

Regarding the survival results, please note that the 2.5-year disease free survival and overall survival in ATO group were 60% and 86% respectively and in ATO plus ATRA group, both disease-free survival and overall survival were 100%. The authors would like to apologise for any inconvenience caused. DOI of original article: 10.1016/j.leukres.2018.01.019 © 2018

Style	Citing Format
MLA	Ghavamzadeh A, et al.. "Corrigendum To: Comparison of Induction Therapy in Non-High Risk Acute Promyelocytic Leukemia With Arsenic Trioxide or in Combination With Atra Leukemia Research 66 (2018) 85–88(S0145212618300250)(10.1016/J.Leukres.2018.01.019)." Leukemia Research, vol. 67, no. , 2018, pp. 116-.
APA	Ghavamzadeh A, Jalili M, Rostami S, Yaghmaie M, Aliabadi LS, Mousavi SA, Vaezi M, Fumani HK, Jahani M, Alimoghaddam K (2018). Corrigendum To: Comparison of Induction Therapy in Non-High Risk Acute Promyelocytic Leukemia With Arsenic Trioxide or in Combination With Atra Leukemia Research 66 (2018) 85–88(S0145212618300250)(10.1016/J.Leukres.2018.01.019). Leukemia Research, 67(), 116-.
Chicago	Ghavamzadeh A, Jalili M, Rostami S, Yaghmaie M, Aliabadi LS, Mousavi SA, Vaezi M, Fumani HK, Jahani M, Alimoghaddam K. "Corrigendum To: Comparison of Induction Therapy in Non-High Risk Acute Promyelocytic Leukemia With Arsenic Trioxide or in Combination With Atra Leukemia Research 66 (2018) 85–88(S0145212618300250)(10.1016/J.Leukres.2018.01.019)." Leukemia Research 67, no. (2018): 116-.
Harvard	Ghavamzadeh A et al. (2018) 'Corrigendum To: Comparison of Induction Therapy in Non-High Risk Acute Promyelocytic Leukemia With Arsenic Trioxide or in Combination With Atra Leukemia Research 66 (2018) 85–88(S0145212618300250)(10.1016/J.Leukres.2018.01.019)', Leukemia Research, 67(), pp. 116-.
Vancouver	Ghavamzadeh A, Jalili M, Rostami S, Yaghmaie M, Aliabadi LS, Mousavi SA, et al.. Corrigendum To: Comparison of Induction Therapy in Non-High Risk Acute Promyelocytic Leukemia With Arsenic Trioxide or in Combination With Atra Leukemia Research 66 (2018) 85–88(S0145212618300250)(10.1016/J.Leukres.2018.01.019). Leukemia Research. 2018;67():116-.
BibTex	@article{ author = {Ghavamzadeh A and Jalili M and Rostami S and Yaghmaie M and Aliabadi LS and Mousavi SA and Vaezi M and Fumani HK and Jahani M and Alimoghaddam K}, title = {Corrigendum To: Comparison of Induction Therapy in Non-High Risk Acute Promyelocytic Leukemia With Arsenic Trioxide or in Combination With Atra Leukemia Research 66 (2018) 85–88(S0145212618300250)(10.1016/J.Leukres.2018.01.019)}, journal = {Leukemia Research}, volume = {67}, number = {}, pages = {116-}, year = {2018} }
RIS	TY - JOUR AU - Ghavamzadeh A AU - Jalili M AU - Rostami S AU - Yaghmaie M AU - Aliabadi LS AU - Mousavi SA AU - Vaezi M AU - Fumani HK AU - Jahani M AU - Alimoghaddam K TI - Corrigendum To: Comparison of Induction Therapy in Non-High Risk Acute Promyelocytic Leukemia With Arsenic Trioxide or in Combination With Atra Leukemia Research 66 (2018) 85–88(S0145212618300250)(10.1016/J.Leukres.2018.01.019) JO - Leukemia Research VL - 67 IS - SP - 116 EP - PY - 2018 ER -

Style

Citing Format

MLA

Ghavamzadeh A, et al.. "Corrigendum To: Comparison of Induction Therapy in Non-High Risk Acute Promyelocytic Leukemia With Arsenic Trioxide or in Combination With Atra Leukemia Research 66 (2018) 85–88(S0145212618300250)(10.1016/J.Leukres.2018.01.019)." Leukemia Research, vol. 67, no. , 2018, pp. 116-.

APA

Ghavamzadeh A, Jalili M, Rostami S, Yaghmaie M, Aliabadi LS, Mousavi SA, Vaezi M, Fumani HK, Jahani M, Alimoghaddam K (2018). Corrigendum To: Comparison of Induction Therapy in Non-High Risk Acute Promyelocytic Leukemia With Arsenic Trioxide or in Combination With Atra Leukemia Research 66 (2018) 85–88(S0145212618300250)(10.1016/J.Leukres.2018.01.019). Leukemia Research, 67(), 116-.

Chicago

Ghavamzadeh A, Jalili M, Rostami S, Yaghmaie M, Aliabadi LS, Mousavi SA, Vaezi M, Fumani HK, Jahani M, Alimoghaddam K. "Corrigendum To: Comparison of Induction Therapy in Non-High Risk Acute Promyelocytic Leukemia With Arsenic Trioxide or in Combination With Atra Leukemia Research 66 (2018) 85–88(S0145212618300250)(10.1016/J.Leukres.2018.01.019)." Leukemia Research 67, no. (2018): 116-.

Harvard

Ghavamzadeh A et al. (2018) 'Corrigendum To: Comparison of Induction Therapy in Non-High Risk Acute Promyelocytic Leukemia With Arsenic Trioxide or in Combination With Atra Leukemia Research 66 (2018) 85–88(S0145212618300250)(10.1016/J.Leukres.2018.01.019)', Leukemia Research, 67(), pp. 116-.

Vancouver

Ghavamzadeh A, Jalili M, Rostami S, Yaghmaie M, Aliabadi LS, Mousavi SA, et al.. Corrigendum To: Comparison of Induction Therapy in Non-High Risk Acute Promyelocytic Leukemia With Arsenic Trioxide or in Combination With Atra Leukemia Research 66 (2018) 85–88(S0145212618300250)(10.1016/J.Leukres.2018.01.019). Leukemia Research. 2018;67():116-.

BibTex

@article{ author = {Ghavamzadeh A and Jalili M and Rostami S and Yaghmaie M and Aliabadi LS and Mousavi SA and Vaezi M and Fumani HK and Jahani M and Alimoghaddam K}, title = {Corrigendum To: Comparison of Induction Therapy in Non-High Risk Acute Promyelocytic Leukemia With Arsenic Trioxide or in Combination With Atra Leukemia Research 66 (2018) 85–88(S0145212618300250)(10.1016/J.Leukres.2018.01.019)}, journal = {Leukemia Research}, volume = {67}, number = {}, pages = {116-}, year = {2018} }

RIS

TY - JOUR
AU - Ghavamzadeh A
AU - Jalili M
AU - Rostami S
AU - Yaghmaie M
AU - Aliabadi LS
AU - Mousavi SA
AU - Vaezi M
AU - Fumani HK
AU - Jahani M
AU - Alimoghaddam K
TI - Corrigendum To: Comparison of Induction Therapy in Non-High Risk Acute Promyelocytic Leukemia With Arsenic Trioxide or in Combination With Atra Leukemia Research 66 (2018) 85–88(S0145212618300250)(10.1016/J.Leukres.2018.01.019)
JO - Leukemia Research
VL - 67
IS -
SP - 116
EP -
PY - 2018
ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract